StockWatch
·

Arcadia Biosciences, Inc. Q1 FY26 Results

RKDAQ1 FY26 Results
Filing
MetricValue ($ M)Q1 FY25
Revenue1.108.3%
Total Income1.108.3%
Expenditure1.88180.6%
PBT
Net Profit-4.39268.9%
OPM-70.82%114.98pp
NPM
EPS-2.11211.1%
View full financials

Arcadia Biosciences Reports Q1 2026 Results; Zola Volumes Up 18% YoY

15 May 2026 · 15 May, 1:43 am

Summary

Arcadia Biosciences announced its financial results for the first quarter of 2026, noting an 18% increase in Zola® coconut water unit volumes. However, total revenues decreased by 8% to $1.1 million compared to the same period last year, primarily due to a revenue reserve release in 2025. The company's net loss attributable to common stockholders was $4.4 million, or $2.11 per share, driven by factors including a loss related to a warrant inducement offer. Management is focused on growing the Zola coconut water brand and evaluating strategic alternatives.

Key Highlights

  1. 1

    Arcadia Biosciences reported that Zola® volumes increased 18% year-over-year in the first quarter of 2026.

  2. 2

    Total revenues decreased by $100,000, or 8%, during the first quarter of 2026 compared to the same period in 2025.

  3. 3

    Selling, general, and administrative expenses decreased by $559,000 during the first quarter of 2026 compared to the same period in 2025.

  4. 4

    Net loss attributable to common stockholders for the first quarter of 2026 was $4.4 million, or $2.11 per share.

  5. 5

    Gross proceeds of approximately $2.1 million were generated from the exercise of previously outstanding preferred investment options during the quarter.

Management Comments

T

T.J. Schaefer

We are very pleased with our performance during the first quarter of 2026. We were able to bring in gross proceeds of approximately $2.1 million from the exercise of previously outstanding preferred investment options, Zola® coconut water revenues and volumes increased at a double-digit rate compared to the same quarter last year, and our selling, general, and administrative expenses are at the lowest level in Arcadia’s history as a public company. Going forward, we continue to evaluate strategic alternatives but also remain focused on growing our Zola coconut water brand and are excited about the prospects of launching a new product that we expect to be on the shelves of many of our largest customers this fall.

Informational and educational content only. Not investment advice.